Kyowa Kirin

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

Boehringer returns to Kyowa with €640M pact for autoimmune drug

Boehringer gave no hint of the small molecule’s modality or what indications it will be tested against first.
James Waldron Oct 30, 2025 6:03am
RNA Concept 3D Render

Japan biotech inks RNA research pact that includes mRNA compounds

Sep 19, 2025 10:49am
cancer target detection radiopharma radio

ASCO: Kura, Kyowa reveal 23% remission rate behind leukemia win

Jun 2, 2025 5:36pm
rocket launch satellite space fly blast off

Amgen ignites Rocket program with wins in phase 3 eczema trials

Mar 10, 2025 5:48am
cancer target detection radiopharma radio

Kura, Kyowa hail ph. 2 win for leukemia drug, but hold back data

Feb 6, 2025 10:40am
pay deal hand over cash licensing transaction money

Kyowa Kirin fronts $330M to share rights to Kura's leukemia drug

Nov 21, 2024 9:35am